查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010036

外科醫療設備市場：2026-2032年全球市場預測（依產品、技術、材料、可攜性、應用、最終用戶和分銷管道分類）

Surgical Devices Market by Product, Technology, Material, Portability, Application, End User, Distribution - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科醫療設備市場價值將達到 177.1 億美元，到 2026 年將成長至 190.5 億美元，到 2032 年將達到 303.5 億美元，複合年成長率為 7.99%。

主要市場統計數據
基準年 2025 177.1億美元
預計年份：2026年 190.5億美元
預測年份 2032 303.5億美元
複合年成長率 (%) 7.99%

為企業決策者提供權威的介紹，概述外科醫療設備市場的範圍、目標和策略意義。

外科醫療設備產業正處於快速變化的臨床需求、快速發展的技術以及複雜的全球供應鏈網路的交匯點。本報告的引言部分說明了影響各器材類別產品開發、部署管道和競爭定位的關鍵因素，旨在為企業主管提供參考。此外，報告還提出了核心研究問題，概述了調查方法，並為負責採購、研發優先排序和商業策略的高階領導者闡明了實際應用案例。

科技、法規和市場的快速變化如何重塑外科手術服務的提供方式，並重新定義每個醫療設備類別的競爭優勢？

近年來，變革性的變化加速了外科醫療服務和醫療設備研發的步伐。微創和機器人輔助手術技術的進步不斷重塑臨床路徑，縮短了患者復原時間，並擴大了門診手術的可能性。同時，能量平台和精準治療方法日益成熟，能夠實現更精準的組織相互作用，並拓展了以往僅限於急診治療的醫療設備的治療範圍。

評估 2025 年美國關稅對外科醫療設備供應鏈、籌資策略和臨床夥伴關係的累積影響。

美國2025年的關稅政策調整為本已複雜的全球供應鏈引入了新的變數，改變了零件採購的經濟效益、製造地的選擇以及跨境庫存策略。關稅政策促使企業重新審視供應鏈設計方案，並引發了諸如重新調整採購優先事項、增加庫存緩衝以及重新談判供應商合約以抵消額外成本等短期戰術性措施。這些調整也將影響資本配置決策以及企業未來在哪些地區投資生產能力。

策略性細分洞察揭示了產品、應用、技術、最終用戶、材料、便攜性和分銷動態如何影響採用模式。

了解市場區隔對於制定產品策略和商業化計劃至關重要。基於產品的市場分析涵蓋內視鏡、能量型醫療設備、外科植入、外科器械和手術機器人。能量型醫療設備在分析中進一步細分為電外科、射頻和超音波技術，每種技術都對應不同的應用場景和監管路徑。外科植入分為心血管、牙科、神經和整形外科四個子領域，每個領域都有其自身的臨床證據要求和植入流程。外科器械分為入路器械、內視鏡器械和通用器械，這些分類會影響消毒通訊協定、一次性使用策略和臨床醫生培訓要求。

區域分析重點在於全球主要市場和樞紐的需求推動要素、法規環境、供應鏈韌性和創新熱點。

區域趨勢顯著影響技術採納和企業投資重點。在美洲，需求趨勢顯示，集中化的私人醫療網路與大規模公共醫療系統並存，後者優先考慮基於價值的採購和縮短病患住院時間。在此背景下，人們對能夠減少住院時間和降低總治療成本的微創和門診相容設備越來越感興趣。該地區的監管流程強調安全性和實際應用效果。因此，早期採用者通常會結合臨床初步試驗和健康經濟學證據，說服大規模醫療機構認可其價值提案。

整合主要醫療設備製造商的產品系列、夥伴關係關係、製造地和投資趨勢的競爭資訊。

企業級洞察著重分析主要企業如何將策略轉化為產品組合決策、合作夥伴選擇和營運執行。主要競爭對手致力於建立端到端解決方案，將醫療設備和服務、軟體和培訓相結合，以確保醫療效果並符合醫院的品質目標。許多公司正超越單一產品競爭，轉而建立平台，透過耗材、資訊服務和特定手術產品創造持續的收入來源。

為行業領導者提供切實可行的建議，以優先考慮投資和夥伴關係，從而加速安全有效地部署外科創新技術。

領導者應優先考慮如何最大限度地提高臨床和商業性效益，同時增強韌性。首先，產品開發應與明確的臨床路徑和報銷要求保持一致，確保新產品上市能夠直接應對醫療服務提供者面臨的挑戰並符合支付方的標準。應儘早投資於上市後資料收集，將其作為臨床開發的重要組成部分，以縮短從核准到醫院廣泛應用的時間。其次，應透過供應商多元化、確保區域製造地以及提高對二級和三級供應商的透明度，重組供應鏈以降低關稅和地緣政治風險。這些措施將有助於降低營運風險，並確保手術的連續性。

調查方法概述了資料來源、相關人員訪談、檢驗程序和研究局限性，以確保嚴格的證據整合。

本調查方法結合了系統性的二手資料研究、與關鍵相關人員的對話以及結構化檢驗，旨在得出可操作的見解。二手資料包括監管文件、同行評審的臨床文獻、醫療設備附加檔和上市公司披露信息，用於建立技術、材料和醫療設備使用特徵的基準。一手資料研究包括對臨床醫生、供應鏈和採購主管、監管專家以及行業策略家的訪談，以了解實際應用中的障礙、採購偏好和未滿足的臨床需求。

一份權威、全面的分析報告，清楚地​​概述了技術、監管和經濟趨勢對建構外科醫療設備產品組合的領導者的戰略意義。

總之，本報告總結了高階主管在技術進步和供應鏈日益複雜的環境下需要應對的關鍵要點。微創手術和能量平台的技術創新不斷改變臨床工作流程，而監管和採購壓力凸顯了對可驗證的成果和成本效益的迫切需求。不斷變化的供應鏈和貿易政策迫使各組織重新評估籌資策略，並投資於生產的柔軟性和透明度。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科醫療設備市場：依產品分類

  • 內視鏡
  • 基於能量的設備
    • 用於電外科手術
    • 高頻
    • 超音波
  • 外科植入
    • 心血管系統
    • 牙科
    • 神經
    • 整形外科
  • 手術器械
    • 存取裝置
    • 內視鏡
    • 整體的
  • 手術機器人

第9章 外科醫療設備市場：依技術分類

  • 高強度聚焦超音波
  • 雷射手術
  • 微創
    • 內視鏡
    • 腹腔鏡手術
    • 機器人支援
  • 開放性手術

第10章 外科醫療設備市場：依材料分類

  • 複合材料
  • 聚合物
  • 不銹鋼
  • 鈦

第11章：外科醫療設備市場－便攜性

  • 攜帶式的
  • 固定式

第12章 外科醫療設備市場：依應用領域分類

  • 循環系統
  • 整體的
  • 婦科
  • 神經外科
  • 整形外科
  • 泌尿系統

第13章 外科醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
  • 專業外科中心

第14章：依分銷管道分類的外科醫療設備市場

  • 離線
  • 線上

第15章 外科醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 外科醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 外科醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國外科醫療設備市場

第19章：中國外科醫療設備市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acumed LLC
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • CONMED Corporation
  • Corin Group plc
  • DePuy Synthes, Inc.
  • Enovis Corporation
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Paragon 28, Inc.
  • SeaSpine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-434CCDA04F06

The Surgical Devices Market was valued at USD 17.71 billion in 2025 and is projected to grow to USD 19.05 billion in 2026, with a CAGR of 7.99%, reaching USD 30.35 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.71 billion
Estimated Year [2026] USD 19.05 billion
Forecast Year [2032] USD 30.35 billion
CAGR (%) 7.99%

An authoritative introduction outlining the scope, objectives, and strategic relevance of the surgical devices landscape for executive decision-makers

The surgical devices domain sits at the intersection of fast-moving clinical need, rapid technological advancement, and complex global supply networks. This report's introduction orients executive readers to the principal forces shaping product development, adoption pathways, and competitive positioning across device categories. It frames the core research questions, outlines the methodological approach, and clarifies the practical use cases for senior leaders responsible for procurement, R&D prioritization, and commercial strategy.

Beginning with clinical imperatives, the introduction connects evolving standards of care and demographic pressure points to the innovation priorities of device manufacturers and health systems. It then transitions to the regulatory and reimbursement context, emphasizing how policy shifts and payer expectations alter commercialization pathways. Finally, the introduction highlights the interplay between manufacturing footprint decisions and logistical resilience, establishing a baseline for later sections that explore segmentation, regional dynamics, and company-level strategies. This orientation prepares readers to interpret the evidence with an operational mindset and to apply the insights to near-term planning cycles.

How rapid technological, regulatory, and market forces are reshaping surgical care delivery and redefining competitive advantage across device categories

Over the last several years, transformative shifts have accelerated the pace at which surgical care is delivered and devices are developed. Advances in minimally invasive and robotic-assisted techniques continue to redefine clinical pathways by reducing patient recovery time and expanding outpatient procedure feasibility. At the same time, energy-based platforms and precision modalities have matured, enabling more targeted tissue interaction and broadening the therapeutic footprint of devices previously confined to acute settings.

Concurrently, supply chain resilience and manufacturing agility have moved to the forefront of strategic planning. Manufacturers now prioritize flexible production lines and dual-source procurement to mitigate disruptions. Regulatory and compliance landscapes have also adapted, with regulators increasingly emphasizing real-world evidence and post-market surveillance as part of approval and lifecycle management processes. These regulatory dynamics create both friction and opportunity: companies that align clinical evidence generation with regulatory expectations can shorten commercialization timelines and reduce reimbursement friction.

Finally, the competitive architecture has shifted toward ecosystems rather than single-product plays. Partnerships across medtech, software, and services create bundled offerings that deliver clinical and operational value beyond product specifications. As payers and providers demand demonstrable outcomes and cost-effectiveness, companies that invest in integrated care solutions and data-driven value propositions will secure differentiated positions in procurement conversations.

Assessing the cumulative impact of United States tariffs in 2025 on supply chains, procurement strategies and clinical partnerships in surgical devices

United States tariff policy changes in 2025 introduced a new variable into an already complex global supply environment, altering the economics of component sourcing, manufacturing location decisions, and cross-border inventory strategies. Tariffs increased the impetus for companies to examine supply chain design choices, prompting near-term tactical responses such as reprioritizing procurement, raising inventory buffers, and renegotiating supplier contracts to offset incremental costs. Over time, these adjustments influence capital allocation decisions and where companies choose to invest in manufacturing capacity.

In addition to direct cost impacts, tariff shifts affected strategic partnerships and clinical collaborations. Providers and device manufacturers reassessed vendor relationships to ensure continuity of critical consumables and to reduce exposure to tariff volatility. This led to greater interest in domestically sourced components or alternate regional suppliers. Investment in supply chain visibility and analytics accelerated, as leaders sought to quantify exposure and model scenario impacts on product availability for elective and urgent procedures.

Finally, the tariff environment contributed to a renewed focus on design for manufacturability and material choices that reduce dependence on tariff-sensitive inputs. Organizations moved to validate alternative materials and to adapt product architectures where clinically feasible. These cumulative responses demonstrate how trade policy can cascade through procurement practices, clinical supply reliability, and long-term innovation strategies, prompting a rebalancing of risk and resilience considerations across the device lifecycle.

Strategic segmentation insights revealing product, application, technology, end user, material, portability and distribution dynamics shaping adoption patterns

Understanding segmentation is essential for shaping product strategy and commercialization plans. Based on Product, market analysis includes Endoscopes, Energy-Based Devices, Surgical Implants, Surgical Instruments, and Surgical Robots. Within Energy-Based Devices, the analysis further distinguishes Electrosurgical, Radio Frequency, and Ultrasound technologies, reflecting distinct clinical use cases and regulatory pathways. Surgical Implants are categorized into Cardiovascular, Dental, Neurological, and Orthopedic subsegments, each governed by unique clinical evidence requirements and implantation workflows. Surgical Instruments are differentiated across Access Devices, Endoscopic, and General instrument groups, which influence sterilization protocols, disposable strategies, and clinician training demands.

When viewed Based on Application, the report tracks device intersection with Cardiovascular, General, Gynecology, Neurological, Orthopedic, and Urology indications, connecting clinical outcomes imperatives to adoption timing and purchasing behavior. Based on Technology, technologies of interest include High-Intensity Focused Ultrasound, Laser Surgery, Minimally Invasive, and Open Surgery. The Minimally Invasive category is further subdivided into Endoscopic, Laparoscopic, and Robotic Assisted techniques, an important distinction because each pathway entails different capital equipment, procedural staffing, and training investments for provider organizations.

From the end-user perspective, Based on End User, the study evaluates demand dynamics across Ambulatory Surgical Centers, Clinics, Hospitals, and Specialty Surgical Centers, recognizing that care setting influences purchasing cycles, sterilization infrastructure needs, and reimbursement contexts. Materials matter as well; Based on Material, devices and implants are examined across Composite, Polymers, Stainless Steel, and Titanium selections, which affect device longevity, biocompatibility considerations, and cost structure. Finally, Based on Portability, the market differentiates Portable versus Stationary solutions, and Based on Distribution, the analysis considers Direct Sales, Distributors, and Online Sales channels. This layered segmentation provides a nuanced view that links product architecture to clinical workflows, procurement behavior, and channel economics.

Regional intelligence highlighting demand drivers, regulatory environments, supply chain resilience, and innovation hotspots across key global markets and hubs

Regional dynamics materially shape how technologies diffuse and how companies prioritize investments. In the Americas, demand patterns reflect a concentrated private provider network alongside large public health systems that emphasize value-based procurement and shorter patient stays. This environment drives interest in minimally invasive and ambulatory-capable devices that reduce length of stay and total episode cost. Regulatory pathways in the region emphasize both safety and real-world performance; as a result, early adopters often couple clinical pilots with health-economic evidence to convince larger providers of the value proposition.

In Europe, Middle East & Africa, heterogeneous regulatory regimes, procurement frameworks, and healthcare financing models create both complexity and opportunity. Fragmented reimbursement landscapes mean that localized clinical and economic value arguments prove necessary. Supply chain resilience remains a priority across the region, and manufacturers frequently adopt region-specific manufacturing or distribution strategies to maintain competitive pricing while meeting regulatory compliance.

Asia-Pacific markets are notable for rapid technology uptake in select urban centers, aggressive investment in surgical robotics and minimally invasive platforms, and growing domestic manufacturing capabilities. The pace of adoption varies with local clinician training capacity and funding models, but the region collectively represents fertile ground for scalable manufacturing strategies and partnerships that target both high-volume urban centers and expanding secondary markets. Across regions, leaders must tailor go-to-market approaches to local procurement drivers, regulatory expectations, and clinical workforce realities while maintaining a coherent global product and evidence strategy.

Competitive intelligence synthesizing product portfolios, partnerships, manufacturing footprints and investment trends among leading device manufacturers

Company-level insights focus on how leading organizations translate strategy into portfolio decisions, partner selection, and operational execution. Top competitors concentrate on building end-to-end solutions that combine devices with services, software, and training to lock in clinical outcomes and align with hospital quality goals. Many firms have moved beyond single-product competition to create platforms that enable recurring revenue streams through consumables, data services, and procedure-specific offerings.

Strategic alliances and M&A activity continue to reconfigure capability maps, with mid-sized firms often acting as innovation engines that larger players acquire to accelerate entry into adjacent technology areas. Manufacturing footprint optimization and investments in automation have become important differentiators for players seeking to reduce per-unit cost volatility and to maintain supply assurance for high-use consumables. Meanwhile, companies that demonstrate robust post-market surveillance and that invest in real-world evidence generation find improved receptivity among payers and health systems.

Finally, commercial models are evolving. Direct sales remain key in high-touch, capital-intensive segments, while distributors and digital channels expand access for lower-cost or consumable-driven product lines. The ability of a company to align its sales model to the customer setting-ambulatory center versus tertiary hospital, for example-affects adoption speed and long-term account penetration. These trends underscore the need for an integrated approach to portfolio management, operational resilience, and customer engagement.

Actionable recommendations for industry leaders to prioritize investments and partnerships that accelerate safe and efficient surgical innovation adoption

Leaders should prioritize actions that enhance resilience while unlocking clinical and commercial upside. First, align product development with clearly defined clinical pathways and reimbursement evidence needs so that new launches directly address provider pain points and payer thresholds. Invest early in post-market data collection as an integral part of clinical development to shorten the time from approval to widespread hospital adoption. Second, re-evaluate supply chain architectures to reduce tariff and geopolitical exposure by diversifying suppliers, creating regional manufacturing options, and increasing visibility into tier-two and tier-three sourcing. These steps will reduce operational risk and protect procedure continuity.

Third, cultivate partnerships across technology, software, and services to build bundled solutions that deliver measurable outcomes and operational efficiencies. Such collaborations not only improve competitiveness but also create higher switching costs for customers. Fourth, tailor commercialization strategies to care settings by deploying direct sales in capital-intensive hospital segments while leveraging distributors and digital channels for ambulatory and consumable-driven markets. Finally, embed adaptive pricing and contracting approaches that reflect value-based procurement trends, enabling more flexible engagement with payers and large provider networks.

Taken together, these recommendations balance risk mitigation with growth orientation, providing leaders with a pragmatic roadmap for prioritizing investments, forging strategic alliances, and operationalizing evidence generation to support sustainable clinical adoption.

Research methodology outlining data sources, stakeholder interviews, validation procedures and study limitations to ensure rigorous evidence synthesis

The research methodology combines systematic secondary research with primary stakeholder engagement and structured validation to produce actionable findings. Secondary inputs included regulatory filings, peer-reviewed clinical literature, device labeling documents, and public company filings to establish baseline technology, material, and device usage characteristics. Primary research included interviews with clinicians, supply chain and procurement executives, regulatory specialists, and industry strategists to capture real-world adoption barriers, procurement preferences, and unmet clinical needs.

Analytical frameworks applied in the study include value chain mapping, scenario-based supply chain stress testing, and comparative product capability assessment. Where appropriate, evidence triangulation validated claims about clinical performance, manufacturing implications, and commercial traction. The methodology also documents limitations, including variability across local reimbursement pathways and differences in clinician training programs that affect adoption timing. To address these constraints, the study reports confidence bounds around qualitative judgments and specifies instances where local validation is recommended.

Overall, this structured approach ensures the findings are grounded in multiple data streams and stakeholder perspectives. It also creates traceability between observations, underlying evidence, and the conclusions presented, supporting both internal strategy discussions and external stakeholder briefings.

Conclusive synthesis articulating the strategic implications of technological, regulatory and economic trends for leaders shaping surgical device portfolios

The conclusion synthesizes the report's principal takeaways for executives seeking to navigate an environment of technological advance and supply chain complexity. Technological innovation in minimally invasive procedures and energy-based platforms continues to reshape clinical workflows, while regulatory and procurement pressures emphasize the need for demonstrable outcomes and cost-effectiveness. Supply chain and trade policy shifts compel organizations to reassess sourcing strategies and to invest in manufacturing flexibility and visibility.

Taken together, these dynamics favor companies that can combine clinical differentiation with operational resilience and who can present compelling, evidence-based value propositions to payers and providers. Strategic partnerships, targeted capital allocation, and adaptable commercialization models will determine which organizations capture sustained adoption across care settings. Leaders should therefore apply the report's segmentation and regional insights to prioritize initiatives that align with both near-term operational needs and long-term portfolio ambitions.

In sum, the surgical devices landscape rewards integrated thinking: those that coordinate product design, supply chain strategy, and clinical evidence generation will be best positioned to convert innovation into lasting clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Devices Market, by Product

  • 8.1. Endoscopes
  • 8.2. Energy-Based Devices
    • 8.2.1. Electrosurgical
    • 8.2.2. Radio Frequency
    • 8.2.3. Ultrasound
  • 8.3. Surgical Implants
    • 8.3.1. Cardiovascular
    • 8.3.2. Dental
    • 8.3.3. Neurological
    • 8.3.4. Orthopedic
  • 8.4. Surgical Instruments
    • 8.4.1. Access Devices
    • 8.4.2. Endoscopic
    • 8.4.3. General
  • 8.5. Surgical Robots

9. Surgical Devices Market, by Technology

  • 9.1. High-Intensity Focused Ultrasound
  • 9.2. Laser Surgery
  • 9.3. Minimally Invasive
    • 9.3.1. Endoscopic
    • 9.3.2. Laparoscopic
    • 9.3.3. Robotic Assisted
  • 9.4. Open Surgery

10. Surgical Devices Market, by Material

  • 10.1. Composite
  • 10.2. Polymers
  • 10.3. Stainless Steel
  • 10.4. Titanium

11. Surgical Devices Market, by Portability

  • 11.1. Portable
  • 11.2. Stationary

12. Surgical Devices Market, by Application

  • 12.1. Cardiovascular
  • 12.2. General
  • 12.3. Gynecology
  • 12.4. Neurological
  • 12.5. Orthopedic
  • 12.6. Urology

13. Surgical Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals
  • 13.4. Specialty Surgical Centers

14. Surgical Devices Market, by Distribution

  • 14.1. Offline
  • 14.2. Online

15. Surgical Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Surgical Devices Market

19. China Surgical Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Acumed LLC
  • 20.6. Arthrex, Inc.
  • 20.7. B. Braun Melsungen AG
  • 20.8. CONMED Corporation
  • 20.9. Corin Group plc
  • 20.10. DePuy Synthes, Inc.
  • 20.11. Enovis Corporation
  • 20.12. Exactech, Inc.
  • 20.13. Globus Medical, Inc.
  • 20.14. Integra LifeSciences Holdings Corporation
  • 20.15. Medtronic plc
  • 20.16. MicroPort Scientific Corporation
  • 20.17. NuVasive, Inc.
  • 20.18. Orthofix Medical Inc.
  • 20.19. Paragon 28, Inc.
  • 20.20. SeaSpine Holdings Corporation
  • 20.21. Smith & Nephew plc
  • 20.22. Stryker Corporation
  • 20.23. Zimmer Biomet Holdings, Inc.
  • 20.24. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. GCC SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 245. GCC SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. GCC SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 250. GCC SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. GCC SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. GCC SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. GCC SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 279. G7 SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. G7 SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 281. G7 SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 282. G7 SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 284. G7 SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. G7 SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 288. G7 SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. G7 SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. G7 SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 291. NATO SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. NATO SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 293. NATO SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. NATO SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 295. NATO SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 296. NATO SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. NATO SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 299. NATO SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 300. NATO SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. NATO SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. NATO SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)